Long noncoding RNA CRNDE functions as a competing endogenous RNA to promote metastasis and oxaliplatin resistance by sponging miR-136 in colorectal cancer

References

• ParkinDMBrayFFerlayJPisaniPGlobal cancer statistics, 2002CA Cancer J Clin20055527410815761078
   PubMed Web of Science ®Google Scholar
• GuptaGPMassaguéJCancer metastasis: building a frameworkCell2006127467969517110329
   PubMed Web of Science ®Google Scholar
• Concha-BenaventeFSrivastavaRMTrivediSIdentification of the cell-intrinsic and -extrinsic pathways downstream of EGFR and IFNγ that induce PD-L1 expression in head and neck cancerCancer Res20167651031104326676749
   PubMed Web of Science ®Google Scholar
• ChenJSignaling pathways in HPV-associated cancers and therapeutic implicationsRev Med Virol201525suppl 1245325752815
   PubMed Web of Science ®Google Scholar
• YuHLeeHHerrmannABuettnerRJoveRRevisiting STAT3 signalling in cancer: new and unexpected biological functionsNat Rev Cancer2014141173674625342631
   PubMed Web of Science ®Google Scholar
• ChenJZhangXDProudCDissecting the signaling pathways that mediate cancer in PTEN and LKB1 double-knockout miceSci Signal20158392pe126329580
   PubMed Web of Science ®Google Scholar
• Van CutsemERiveraFBerrySSafety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT studyAnn Oncol200920111842184719406901
   PubMed Web of Science ®Google Scholar
• RedmondKLPapafiliALawlerMVan SchaeybroeckSOvercoming resistance to targeted therapies in cancerSemin Oncol201542689690826615134
   PubMedGoogle Scholar
• TemrazSMukherjiDAlameddineRShamseddineAMethods of overcoming treatment resistance in colorectal cancerCrit Rev Oncol Hematol201489221723024075059
   PubMedGoogle Scholar
• ZhengJLiuXWangPCRNDE promotes malignant progression of glioma by attenuating miR-384/PIWIL4/STAT3 axisMol Ther20162471199121527058823
   PubMed Web of Science ®Google Scholar
• ZhengJLiXDWangPCRNDE affects the malignant biological characteristics of human glioma stem cells by negatively regulating miR-186Oncotarget2015628253392535526231038
   PubMedGoogle Scholar
• LiuTZhangXYangYMDuLTWangCXIncreased expression of the long noncoding RNA CRNDE-h indicates a poor prognosis in colorectal cancer, and is positively correlated with IRX5 mRNA expressionOnco Targets Ther201691437144827042112
   PubMed Web of Science ®Google Scholar
• ChenWYangYChenBMiR-136 targets E2F1 to reverse cisplatin chemosensitivity in glioma cellsJ Neurooncol20141201435325139024
   PubMed Web of Science ®Google Scholar
• WuHLiuQCaiTChenYDLiaoFWangZFMiR-136 modulates glioma cell sensitivity to temozolomide by targeting astrocyte elevated gene-1Diagn Pathol2014917325266957
   PubMed Web of Science ®Google Scholar
• RevetIFeeneyLBrugueraSFunctional relevance of the histone gammaH2Ax in the response to DNA damaging agentsProc Natl Acad Sci U S A2011108218663866721555580
   PubMed Web of Science ®Google Scholar
• SchmittAMChangHYGene regulation: long RNAs wire up cancer growthNature2013500746453653723945584
   PubMed Web of Science ®Google Scholar
• KellandLThe resurgence of platinum-based cancer chemotherapyNat Rev Cancer20077857358417625587
   PubMed Web of Science ®Google Scholar
• HolohanCVan SchaeybroeckSLongleyDBJohnstonPGCancer drug resistance: an evolving paradigmNat Rev Cancer2013131071472624060863
   PubMed Web of Science ®Google Scholar
• Martinez-BalibreaEMartínez-CardúsAGinésATumor-related molecular mechanisms of oxaliplatin resistanceMol Cancer Ther20151481767177626184483
   PubMed Web of Science ®Google Scholar
• EkbladLJohnssonACetuximab sensitivity associated with oxaliplatin resistance in colorectal cancerAnticancer Res201232378378622399593
   PubMedGoogle Scholar
• ChenJHuangXFQiaoLKatsifisAInsulin caused drug resistance to oxaliplatin in colon cancer cell line HT29J Gastrointest Oncol201121273322811824
   PubMedGoogle Scholar
• NemotoSNakamuraMOsawaYSphingosine kinase isoforms regulate oxaliplatin sensitivity of human colon cancer cells through ceramide accumulation and Akt activationJ Biol Chem200928416104221043219240026
   PubMed Web of Science ®Google Scholar
• BartonicekNMaagJLDingerMELong noncoding RNAs in cancer: mechanisms of action and technological advancementsMol Cancer20161514327233618
   PubMed Web of Science ®Google Scholar
• LavorgnaGVagoRSarminiMMontorsiFSaloniaABelloneMLong non-coding RNAs as novel therapeutic targets in cancerPharmacol Res201611013113827210721
   PubMed Web of Science ®Google Scholar
• RiquelmeIIliCRoaJCBrebiPLong non-coding RNAs in gastric cancer: mechanisms and potential applicationsOncotarget Epub2016516
   Google Scholar
• QiPZhouXYDuXCirculating long non-coding RNAs in cancer: current status and future perspectivesMol Cancer20161513927189224
   PubMed Web of Science ®Google Scholar
• QianXYuJYinYMicroRNA-143 inhibits tumor growth and angiogenesis and sensitizes chemosensitivity to oxaliplatin in colorectal cancersCell Cycle20131291385139423574723
   PubMed Web of Science ®Google Scholar
• ZhangLPickardKJeneiVmiR-153 supports colorectal cancer progression via pleiotropic effects that enhance invasion and chemotherapeutic resistanceCancer Res201373216435644723950211
   PubMed Web of Science ®Google Scholar
• ZhouYWanGSpizzoRmiR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinaseMol Oncol201481839224145123
   PubMed Web of Science ®Google Scholar
• CrosbyMEAlmasanAOpposing roles of E2Fs in cell proliferation and deathCancer Biol Ther20043121208121115662116
   PubMed Web of Science ®Google Scholar
• MaYXinYLiRTFDP3 was expressed in coordination with E2F1 to inhibit E2F1-mediated apoptosis in prostate cancerGene2014537225325924406621
   PubMed Web of Science ®Google Scholar
• CataldoACheungDGBalsariAmiR-302b enhances breast cancer cell sensitivity to cisplatin by regulating E2F1 and the cellular DNA damage responseOncotarget20167178679726623722
   PubMed Web of Science ®Google Scholar
• ChangWYAndrewsJCarterDEDagninoLDifferentiation and injury-repair signals modulate the interaction of E2F and pRB proteins with novel target genes in keratinocytesCell Cycle20065161872187916931907
   PubMed Web of Science ®Google Scholar
• LiZHouMWangHWangZA randomized study of gemcitabine plus oxaliplatin versus gemcitabine plus cisplatin as the 1st line chemotherapy for advanced non-small cell lung cancer in elderly patientsZhongguo Fei Ai Za Zhi201114758859221762628
   PubMedGoogle Scholar
• LaineAWestermarckJMolecular pathways: harnessing E2F1 regulation for prosenescence therapy in p53-defective cancer cellsClin Cancer Res201420143644365024788101
   PubMedGoogle Scholar
• KnollSEmmrichSPutzerBMThe E2F1-miRNA cancer progression networkAdv Exp Med Biol201377413514723377972
   PubMedGoogle Scholar
• Vélez-CruzRJohnsonDGE2F1 and p53 transcription factors as accessory factors for nucleotide excision repairInt J Mol Sci20121310135541356823202967
   PubMedGoogle Scholar
• EngelmannDPützerBMThe dark side of E2F1: in transit beyond apoptosisCancer Res201272357157522298593
   PubMed Web of Science ®Google Scholar
• ZhanLZhangYWangWSongEFanYWeiBE2F1: a promising regulator in ovarian carcinomaTumour Biol20163732823283126749284
   PubMedGoogle Scholar
• Poppy RoworthAGhariFLa ThangueNBTo live or let die – complexity within the E2F1 pathwayMol Cell Oncol201521e97048027308406
   PubMedGoogle Scholar